Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Neuropathic Pain
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 70 years
Gender
Both males and females

Description

The secondary objectives of this study are: to show a superiority of hypnosis and relaxation over control group on neuropathic pain. to show a lasting effect of treatment on neuropathic pain one week after the end of treatment. to evaluate the clinical predictors of response to hypnosis (nature of n...

The secondary objectives of this study are: to show a superiority of hypnosis and relaxation over control group on neuropathic pain. to show a lasting effect of treatment on neuropathic pain one week after the end of treatment. to evaluate the clinical predictors of response to hypnosis (nature of neuropathic symptoms, severity of anxiety and depressive symptoms, pain catastrophizing, coping strategies, emotional regulation, response to the first session, positive or negative emotional reaction at the end of hypnosis sessions). to evaluate the effect of hypnosis at long-term (1, 3 and 6 months after the end of treatment). to evaluate the effect of hypnosis on emotional processes. to compare hypnosis to relaxation on short-term effects on pain, to evaluate the quality of life and the impact of pain on daily life: sleep, mood, anxiety symptoms, analgesics consumption , neuropathic symptoms, affective component of pain and pain catastrophizing. 35 patients will be enrolled in each arm, to obtain 105 in total (3 arms). Total duration for each patient: 8 months.

Tracking Information

NCT #
NCT02256371
Collaborators
Not Provided
Investigators
Principal Investigator: Nadine ATTAL, MD, PhD Groupe Hospitalier Ambroise Paré